https://www.theguardian.com/global-deve ... l-parasite
Human trials of new antimalarial drugs are in the pipeline after Kenyan scientists successfully used bacteria to kill the parasite that causes the disease.
The Kenya Medical Research Institute (Kemri) and global health partners say the breakthrough could potentially lead to the development of a new class of drugs in less than two years.
The promise of a new treatment comes after vaccine trials in Burkina Faso proved that Ivermectin, a conventional drug used for parasitic diseases including river blindness and elephantiasis, reduced transmission rates. The medication worked by making the blood of people who were repeatedly vaccinated lethal to mosquitoes.
The study also found that Ivermectin can kill plasmodium falciparum, the malaria parasite carried by female mosquitoes, when administered to humans.
Malaria affects more than 200 million people globally and claims nearly 500,000 lives a year, with children especially vulnerable. Photograph: University of Glasgow/PA
The US-based Centers for Disease Control and Prevention will now perform human trials using new drugs derived from the bacteria after extensive lab research.
Looking for advise on hospitals, dentists and other health issues? Ask here.
1 post • Page 1 of 1